Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for

Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Home > Hedge Funds > Armistice Capital > Profile

Hedge Fund - Armistice Capital

Steven Boyd Bio, Returns, AUM, Net Worth

Manager biography is currently missing.
Steven Boyd
Fund Profile
Filing Period:
Fund Name: Armistice Capital
Manager Steven Boyd
Portfolio Value $1,826,995,000
Change This QTR +1.38%
Fund Holdings Sector Distribution
Top 13F Holdings
Filing Period:
Last update:
No. Security Ticker Shares Value (x$1000) Activity % Port
1.
Spdr S & P 500 Etf TrustPUT
 SPY 1,600,000 $451,968 +7% 24.73%
2.
Cerecor Inc.
 CERC 18,304,285 $106,897 +1% 5.85%
3.
Cvs Health CorpCALL
 CVS 1,250,000 $74,913 +525% 4.1%
4.
Energizer Holdings Inc.
 ENR 1,296,000 $58,229 +22% 3.18%
5.
Celgene Corp
 CELG 592,000 $55,849 3.05%
News, Interviews and Investor Letters
See All
Hedge Fund and Insider Trading News: Kora Management, Glendon Capital, Armistice Capital, Hill International Inc (HIL), Athenex Inc (ATNX), and More

Hedge Fund and Insider Trading News: Kora Management, Glendon Capital, Armistice Capital, Hill International Inc (HIL), Athenex Inc (ATNX), and More

Jared Kushner, US President Donald Trump’s son-in-law, arrived in Jaisalmer on Friday, 23 November to attend his friend Nitin Saigal’s wedding. The founding partner of the US hedge fund firm Kora...... (read more)

November 23rd, 2018 - Hedge Funds Insider Trading - Comments

13G Filing: Armistice Capital and Onconova Therapeutics Inc. (ONTX)

13G Filing: Armistice Capital and Onconova Therapeutics Inc. (ONTX)

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...... (read more)

February 21st, 2018 - Hedge Funds - Comments

13G Filing: Armistice Capital and Intellipharmaceutics Intl Inc (IPCI)

13G Filing: Armistice Capital and Intellipharmaceutics Intl Inc (IPCI)

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...... (read more)

December 5th, 2017 - Hedge Funds - Comments

13G Filing: Armistice Capital and Check Cap Ltd (CHEK)

13G Filing: Armistice Capital and Check Cap Ltd (CHEK)

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...... (read more)

December 1st, 2017 - Hedge Funds - Comments

13G Filing: Armistice Capital and Biopharmx Corp (BPMX)

13G Filing: Armistice Capital and Biopharmx Corp (BPMX)

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...... (read more)

December 1st, 2017 - Hedge Funds - Comments

13D Filing: Armistice Capital and Cerecor Inc (CERC)

13D Filing: Armistice Capital and Cerecor Inc (CERC)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.240.13d-1(e), 240.13d...... (read more)

November 25th, 2017 - Hedge Funds - Comments

13G Filing: Armistice Capital and Tandem Diabetes Care Inc (TNDM)

13G Filing: Armistice Capital and Tandem Diabetes Care Inc (TNDM)

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...... (read more)

October 24th, 2017 - Hedge Funds - Comments

13G Filing: Armistice Capital and IntelliPharmaCeutics Intl Inc (USA) (IPCI)

13G Filing: Armistice Capital and IntelliPharmaCeutics Intl Inc (USA) (IPCI)

                                                                                                                       [...... (read more)

October 23rd, 2017 - Hedge Funds - Comments

13G Filing: Armistice Capital and Strongbridge Biopharma PLC (SBBP)

13G Filing: Armistice Capital and Strongbridge Biopharma PLC (SBBP)

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...... (read more)

September 25th, 2017 - Hedge Funds - Comments

13G Filing: Armistice Capital and Apricus Biosciences Inc. (APRI)

13G Filing: Armistice Capital and Apricus Biosciences Inc. (APRI)

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...... (read more)

September 21st, 2017 - Hedge Funds - Comments

13D Filing: Armistice Capital and Cerecor Inc (CERC)

13D Filing: Armistice Capital and Cerecor Inc (CERC)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.240.13d-1(e), 240.13d...... (read more)

August 31st, 2017 - Hedge Funds - Comments

13G Filing: Armistice Capital and Aytu Bioscience Inc (AYTU)

13G Filing: Armistice Capital and Aytu Bioscience Inc (AYTU)

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...... (read more)

August 25th, 2017 - Hedge Funds - Comments

13G Filing: Armistice Capital and Depomed Inc (DEPO)

13G Filing: Armistice Capital and Depomed Inc (DEPO)

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...... (read more)

August 18th, 2017 - Hedge Funds - Comments

13G Filing: Armistice Capital and Actinium Pharmaceuticals Inc. (ATNM)

13G Filing: Armistice Capital and Actinium Pharmaceuticals Inc. (ATNM)

*  The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing...... (read more)

August 8th, 2017 - Hedge Funds - Comments

13G Filing: Armistice Capital and Histogenics Corp (HSGX)

13G Filing: Armistice Capital and Histogenics Corp (HSGX)

*  The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing...... (read more)

July 11th, 2017 - Hedge Funds - Comments

Click here to See All News
Home Hedge Funds Markets Blog Authors About Us Contact Us Privacy Policy Terms of Use Site Map
All text and design is copyright ©2019 Koala Guide LLC. All rights reserved.